Comparing Two Sleep Drugs Used During Spinal Tumor Surgery
Original title: Remimazolam vs Propofol for Motor and Somatosensory Evoked Potentials in Spinal Tumor Surgery
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a late stage trial, further along than a first test in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
Two sleep drugs are compared to see which keeps nerve signals clearer during surgery.
Who this trial is for. This trial is for adults having planned surgery to remove a spinal tumor. It compares two sleep drugs, remimazolam and propofol, used to keep people asleep during that surgery.
Where it stands. This trial has not reported results. It measures how strong nerve signals stay while the surgeon works on the tumor. It also counts warning alerts during surgery. People are followed for 30 days after surgery. The answer is not in yet.
What this means, and what it doesn't
What it could mean: During spine surgery, a team watches nerve signals to catch harm early. Some sleep drugs make those signals harder to read. This trial asks which drug gives a clearer picture. Someone facing spinal tumor surgery could ask their care team about it.
What it doesn't mean: This does not mean one drug is better. A trial is a test, not proven care. Being in one is not a promise that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.